Large-Vessel Vasculitis (GCA & Takayasu)

Quick Answer

Large-vessel vasculitis — giant cell arteritis (GCA) and Takayasu arteritis — causes granulomatous inflammation of the aorta and its large branches. FDG-PET/CT shows smooth, circumferential, high-grade wall uptake (graded against the liver), mapping disease activity and extent. The single most important practical rule: image before or early in corticosteroid therapy, because steroids rapidly suppress vascular-wall FDG uptake. GCA is a vision-threatening emergency — treatment is not delayed for imaging.

Definition

Large-vessel vasculitis is granulomatous inflammation of large arteries. GCA affects older adults (aorta/branches and cranial arteries, notably the temporal artery) and overlaps with polymyalgia rheumatica (PMR). Takayasu arteritis affects younger patients (typically women < 40), involving the aorta and its primary branches.

Synonyms

Giant cell (temporal) arteritis (GCA); Takayasu arteritis ("pulseless disease"); large-vessel vasculitis (LVV); aortitis (when the aorta is the focus).

Epidemiology

GCA is a disease of adults > 50 (peak 70s), more common in women and in Northern-European populations, and associated with PMR. Takayasu predominantly affects young women, with higher prevalence in Asian populations.

Etiology & Risk Factors

Autoimmune granulomatous vasculitis of uncertain trigger. HLA-DRB1*04 is associated with GCA. Age (GCA) and younger female sex (Takayasu) are the principal demographic risks.

Pathophysiology

Mural granulomatous inflammation (with giant cells in GCA) causes wall thickening, luminal stenosis/occlusion, and aneurysm formation. Cranial-artery involvement in GCA threatens vision (anterior ischemic optic neuropathy) — the reason for urgent steroids. Takayasu produces stenoses, occlusions, and aneurysms of the aorta and branches (limb claudication, pulse/BP asymmetry).

Genetics & Molecular Biology

GCA shows HLA-DRB1*04 and IL-6-pathway involvement (rationale for tocilizumab). Takayasu has distinct HLA associations (e.g. HLA-B*52). Both are polygenic autoimmune disorders.

Histopathology

Granulomatous panarteritis with lymphocytes, macrophages, and multinucleated giant cells and fragmentation of the internal elastic lamina (GCA temporal-artery biopsy — though skip lesions cause sampling error). Takayasu shows similar granulomatous mural inflammation of large elastic arteries.

Clinical Presentation

• GCA: new headache, jaw claudication, scalp tenderness, visual loss/diplopia, constitutional symptoms, and PMR (shoulder/hip girdle pain/stiffness).
• Takayasu: limb claudication, absent/asymmetric pulses, blood-pressure discrepancy, bruits, and constitutional symptoms.

Laboratory Findings

Markedly elevated ESR and CRP (may be lower on steroids). Anemia of inflammation. Temporal-artery biopsy for GCA (skip lesions reduce sensitivity). IL-6 elevation underpins tocilizumab responsiveness.

Imaging Findings by Modality

• Temporal-artery ultrasound (GCA): the "halo" sign (hypoechoic wall edema) and compression sign.
• FDG-PET/CT: smooth circumferential high-grade wall uptake of the aorta and large branches — activity and whole-body extent; grade against liver.
• MRI/MRA and CTA: wall thickening/edema, stenoses, aneurysms (structural extent, especially Takayasu).
• PET/MR: combines metabolic activity and vessel-wall structure (emerging).

Radiopharmaceutical Uptake Mechanisms

FDG accumulates in the activated inflammatory cells of the vessel wall (macrophages, giant cells), reflecting disease activity. This activity-dependence is why corticosteroids rapidly reduce uptake — the basis of the "image before/early" rule.

Typical PET Tracers

Typical SPECT Tracers

• None with a routine role.

Therapy Indications

• High-dose corticosteroids — urgent in GCA to prevent vision loss (do not delay for imaging).
• Tocilizumab (IL-6 receptor blockade) as a steroid-sparing agent (GCA).
• Takayasu: corticosteroids, steroid-sparing immunosuppression, and revascularization for critical stenoses.

Theranostics

None — nuclear medicine's role is diagnosis, extent, and activity monitoring of vascular inflammation.

Differential Diagnosis

• Atherosclerosis: typically patchy, calcified, non-circumferential uptake vs the smooth circumferential pattern of vasculitis.
• Infective (mycotic) aortitis, IgG4-related aortitis/periaortitis, and post-surgical graft inflammation.
• Physiologic large-vessel activity and image-timing artifacts.

Reporting Checklist

• Describe distribution (aorta segments, subclavian/carotid/iliofemoral branches) and grade wall uptake vs liver.
• State steroid status/timing (uptake suppressed on steroids) — critical caveat.
• Distinguish smooth circumferential vasculitic uptake from patchy/calcified atherosclerosis.
• Frame activity for monitoring (matched technique).

Prognosis

GCA carries a real risk of irreversible vision loss if untreated, and both diseases relapse and can cause aneurysm/stenosis. Timely treatment (urgent in GCA) and activity-guided immunosuppression improve outcomes; FDG activity helps assess response and smoldering disease.

Board Pearls

FDG-PET/CT shows smooth, circumferential, high-grade wall uptake of the aorta and large branches (graded vs liver) — mapping vasculitis activity and extent. The essential rule: image before or early in corticosteroids, which rapidly suppress vascular-wall FDG uptake.

GCA is a vision-threatening emergency — start high-dose steroids urgently and do not delay for imaging; the temporal-artery "halo" sign on ultrasound and biopsy (with skip-lesion caveat) support the diagnosis, and tocilizumab is a steroid-sparing option.

Distinguish vasculitis from atherosclerosis — vasculitis is smooth and circumferential, atherosclerosis is patchy and calcified. Consider infective (mycotic) aortitis and IgG4-related periaortitis in the differential. Takayasu (younger women) tends to produce stenoses/occlusions/aneurysms with limb claudication and pulse/BP asymmetry.

Related Pages

• Related: Infection & inflammation (FDG applications), tracer FDG.
• Pitfalls: Pearls, pitfalls & normal variants.

Figure / Diagram Suggestions

• A smooth-circumferential vs patchy-calcified uptake comparison (vasculitis vs atherosclerosis).
• A large-vessel distribution map (aorta + subclavian/carotid/iliofemoral).
• A steroid-timing graphic (uptake suppressed after steroids — image early).

Common Pitfalls

• Reading a negative PET obtained on corticosteroids as excluding vasculitis — steroids blunt vascular-wall uptake within days, so a suppressed study is non-diagnostic, not negative.
• Cranial/temporal-artery GCA is not assessed by whole-body PET (small caliber, adjacent brain uptake) — a normal cephalic PET does not exclude cranial disease; use ultrasound/biopsy.
• Mistaking focal calcified atheroma for vasculitis in older patients, where atherosclerosis and vasculitis frequently coexist — attend to the smooth-circumferential vs patchy-calcified pattern.
• Overcalling relapse from persistent low-grade wall uptake, which can reflect vascular remodeling/repair rather than active inflammation — interpret against baseline and clinical/laboratory activity.
• Degraded wall-to-blood contrast from hyperglycemia, short uptake time, or high blood-pool activity can both mimic and mask disease — confirm adequate preparation before grading.

Self-Check (Board-Style)